Korean Circ J.  2010 Sep;40(9):423-431. 10.4070/kcj.2010.40.9.423.

Clinical Implications of Ambulatory and Home Blood Pressure Monitoring

• Kim SG

• KMID: 1456133
• DOI: http://doi.org/10.4070/kcj.2010.40.9.423

Abstract

Because blood pressure (BP) is an ever changing hemodynamic phenomenon, a BP value, once measured at a physician's office (Office BP), is often unrepresentative of an individual's true BP status. Both ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) provide more accurate and reproducible estimate of BP, and produce stronger predictive ability for cardiovascular outcome than conventional office BP. Two BP measuring techniques, ABPM and HBPM have been widely in clinical use for the detection and management of hypertension. However, they have different advantages and limitations in practice. At present, it has become crucial to understand the characteristics and clinical implications of these BP measuring techniques for those responsible for the care of hypertensive patients.

Keyword

Hypertension; Blood pressure monitoring

MeSH Terms

Benzhydryl Compounds
Blood Pressure
Blood Pressure Monitoring, Ambulatory
Hemodynamics
Humans
Hypertension
Physicians' Offices
Benzhydryl Compounds

Reference

1. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003. 21:821–848.

2. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008. 26:1505–1526.

3. Yoo WS, Park HJ, Lee EY, Choi SK. A representative value for 24-h ambulatory blood pressure monitoring. Korean Circ J. 1985. 15:209–214.

4. Park IS, Rho TH, Park JW, et al. Prevalence of urinary microalbuminuria in normal and hypertensive Koreans and its correlation with blood pressure measured by 24 hours ambulatory blood pressure monitoring. Korean Circ J. 1994. 24:834–840.

5. Jeon HC, Kim YK, Kim KY, et al. Determination of left ventricular mass in healthy adults: a study using echocardiography and 24 hour ambulatory blood pressure monitoring. Korean Circ J. 1995. 25:811–819.

6. Pickering TG, Shimbo D, Hass D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006. 354:2368–2374.

7. Verdecchia P, Angeli F, Mazzotta G, Gentile G, Reboldi G. Home blood pressure measurement will not replace 24-hour ambulatory blood pressure measurement. Hypertension. 2009. [Epub ahead of print].

8. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed?: home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension. 2009. [Epub ahead of print].

9. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 1983. 249:2792–2798.

10. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994. 24:793–801.

11. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997. 15:357–364.

12. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998. 31:712–718.

13. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10 year follow-up study. Circulation. 1998. 98:1892–1897.

14. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999. 282:539–546.

15. Kario K, Shimata K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001. 38:238–245.

16. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk facter: a 10-year follow-up study. J Hum Hypertens. 2003. 17:811–817.

17. Clement DL, Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med. 2003. 348:2407–2415.

18. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003. 107:1297–1302.

19. Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension. Am J Hypertens. 2004. 17:876–881.

20. Fagard RH, Van den Broeke C, De Cort P. Prognostic significance of blood pressure measured in office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005. 19:801–807.

21. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from Pressioni Arteriose Monitorate e Loro Associozioni (PAMELA) Study. Circulation. 2005. 111:1777–1783.

22. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension. 2005. 45:499–504.

23. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinical blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005. 46:156–161.

24. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997. 350:757–764.

25. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part I. blood pressure measurement in humans. A statement for professionals from the sub-committee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension. 2005. 45:142–161.

26. Kikuya M, Hansen TW, Thijs L, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007. 115:2145–2152.

27. Hansen TW, Kikuya M, Thijs L, et al. Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications. J Clin Hypertens (Greenwich). 2008. 10:377–381.

28. Kikuya M, Hansen TW, Thijs L, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Blood Press Monit. 2007. 12:393–395.

29. O'Brien E, Sheridan J, O'Malley K. Dipper and non-dippers. Lancet. 1988. 2:397.

30. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000. 35:844–851.

31. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990. 81:528–536.

32. Kim SJ, Kang HS, Hwang SJ, et al. The relation of circadian blood pressure variation to left ventricular mass, diastolic function and dynamic QT dispersion. Korean Circ J. 2005. 35:382–388.

33. Lee JU, Kim KS, Kim SK, et al. Left ventricular geometric patterns of dippers and non-dippers in essential hypertension. Korean Circ J. 1996. 26:44–51.

34. Lee CK, Her GM, Park GE, et al. Interrelationship between left ventricular mass and diurnal variations of blood pressure in patients with essential hypertension. Korean Circ J. 1997. 27:13–19.

35. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992. 10:875–878.

36. Redon J, Liano Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens. 1994. 12:947–953.

37. Ohkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality: the Ohasama study. Am J Hypertens. 1997. 10:1201–1207.

38. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens. 2004. 22:1691–1697.

39. Boggia J, Li Y, Thijs L, et al. Prognositic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007. 370:1219–1229.

40. Kikuya M, Hozowa A, Ohkubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000. 36:901–906.

41. Rim SJ. Blood pressure variation and cardiovascular risks. Korean Circ J. 2008. 38:131–134.

42. Verdecchia P, Borgioni C, Ciucci A, et al. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit. 1996. 1:3–11.

43. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003. 107:1401–1406.

44. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressure surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006. 47:149–154.

45. Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008. 13:161–162.

46. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hytertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005. 46:508–515.

47. Kim HY, Kwack NJ, Park NK, et al. Influences of white-coat hypertension and white-coat effect on the left ventricular mass and diastolic function. Korean Circ J. 1995. 25:987–997.

48. Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005. 45:203–208.

49. Ugajin T, Hozawa A, Ohkubo T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005. 165:1541–1546.

50. Pickering T, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002. 40:795–796.

51. Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, false resistant, and true resistant hypertension. Am J Hypertens. 2005. 18:1422–1428.

52. Verberk WJ, Kroon AA, Kessels AG, de Leeuw PW. Home blood pressure measurement: a systemic review. J Am Coll Cardiol. 2005. 46:743–751.

53. Mengden T, Chamontin B, Phong CN, LuisPalma GJ, Chanudet X. User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement. Blood Press Monit. 2000. 5:111–129.

54. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006. 47:846–853.

55. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998. 16:971–975.

56. Ohkubo T, Asayama K, Kikuya M, et al. Prediction of ischaemic and heamorrhagic stroke by self-measured blood pressure at home: the Ohasama study. Blood Press Monit. 2004. 9:315–320.

57. Stergiou GS, Zourbaki AS, Skeba II, Mountokalakis TD. White coat effect detecting using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. Am J Hypertens. 1998. 11:820–827.

58. Denolle T, Waeber B, Kjeldsen S, Parati G, Wilson M, Asmar R. Self-measurement of blood pressure in clinical trials and therapeutic applications. Blood Press Monit. 2000. 5:145–149.

59. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004. 291:1342–1349.

60. Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich). 2006. 8:174–180.

61. Logan AG, Dunai A, McIssac WJ, Irvine MJ, Tisler A. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens. 2008. 26:446–452.

62. Mengden T, Hemandez Medina RM, Beltran B, Alvarez E, Kraft K, Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998. 11:1413–1417.

63. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000. 355:865–872.

64. Lurbe E, Invitti C, Torro I, et al. The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens. 2006. 24:1557–1564.

65. Milne F, Redman C, Walker J, et al. The preeclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. BMJ. 2005. 330:576–580.

66. Redon J, Oliver V, Zaragoza MD, Galindo MJ. Ambulatory blood pressure during diseases of the kidney. Blood Press Monit. 1999. 4:267–274.

67. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006. 26:503–510.

68. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Shimada K, Kario K. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertens (Greenwich). 2007. 9:601–607.

69. Rave K, Bender R, Heise T, Sawicki PT. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy. J Hypertens. 1999. 17:597–601.

70. Vaur L, Duborca I, Dutrey-Dupagne C, et al. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit. 1998. 3:107–114.

71. Staessen JA, Den HE, Celis H, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA. 2004. 291:955–964.

72. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomized trials. BMJ. 2004. 329:145.

73. Kim JH, Park JC. Variables and end-points in Korean Ambulatory Blood Pressure (Kor-ABP) registry. J Korean Soc Hypertens. 2009. 15:Suppl I. I74–I80.